NDAC Denavir review
This article was originally published in The Tan Sheet
Executive Summary
FDA advisory committee will meet at Bethesda Holiday Inn, 8120 Wisconsin Ave., Bethesda, Md., at 8:30 a.m. Dec. 1 to consider SmithKline Beecham's switch application for topical penciclovir 1% cream for the treatment of recurrent labial herpes, or cold sores, in immunocompetent adults. The open public hearing will be held from 1-2 p.m. To participate, contact Rhonda Stover or Sandra Titus at (301) 827-7001. Sandra Titus, PhD, formerly of CDER's Office of Compliance, is new executive secretary for NDAC. Tentative meeting dates for 1999 are Feb. 18-19, April 15-16, July 19-20, Oct. 18-19 and Dec. 2-3